Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MI Providers > Ophthalmologists

Dr. Michael Thomas Trese, MD

Claimed Profile

Accepting New Patients

(Michael Trese, MD)

(No ratings)

Specializes in: Ophthalmology (Eye Disease), Optometry (Primary Eye Care) and General Practice

3555 West 13 Mile Road Suite LL-20
Royal Oak, MI 48073

(248) 288-2280

Dr. Michael Thomas Trese, MD is an ophthalmologist in Royal Oak, MI specializing in ophthalmology (eye disease), optometry (primary eye care) and general practice. Dr. Michael Thomas Trese, MD is affiliated with Associated Retinal Consultants.

Office Locations

Address:

3555 West 13 Mile Road Suite LL-20
Royal Oak, MI 48073

In The News

“Associate Professor of Biomedical Sciences and PRRL researcher Kenneth Mitton explained that two Beaumont Hospitals clinicians, Dr. Michael Trese and Dr. Kimberly Drenser, work closely with him,...”—"Grants To Help Eye Research Institute Advance Optical Health Studies", CBS Boston, June 2013

“"Both are known as anti-VEGF drugs," said Michael Trese, M.D., Beaumont retinal specialist and principal investigator for the only Michigan CATT site.”—"Drug stabilizes Berkley musician's vision", Royal Oak Tribune, August 2011

doctor visit	28
eye procedures	2011
injections	397

**Gender**
Male	121
Female	198

**Ethnicity**
Non-Hispanic White	286
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	76
From 75 to 84	109
85 and over	90
Less than 65	44

Hypertension	75
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	51
Depression	16
Chronic Kidney Disease	27
Asthma	8
Osteoperosis	10
Atrial Fibrilation	16
Heart Failure	26
Chronic Obstructive Pulmonary Disease	17
Diabetes	42
Dementia	10
Cancer	11

eye procedures	2137
injections	326

**Gender**
Male	126
Female	200

**Ethnicity**
Non-Hispanic White	297
Black	18
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	90
From 75 to 84	107
85 and over	89
Less than 65	40

Hypertension	71
High Cholesterol	58
Stroke	6
Ischemic Heart Disease	43
Depression	19
Chronic Kidney Disease	26
Asthma	7
Osteoperosis	10
Atrial Fibrilation	15
Heart Failure	22
Chronic Obstructive Pulmonary Disease	14
Diabetes	40
Dementia	9
Cancer	7

eye procedures	1970
injections	290

**Gender**
Male	232
Female	382

**Ethnicity**
Non-Hispanic White	556
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	178
From 75 to 84	170
85 and over	180
Less than 65	86

Hypertension	73
High Cholesterol	57
Stroke	4
Ischemic Heart Disease	44
Depression	16
Chronic Kidney Disease	30
Asthma	11
Osteoperosis	11
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	14
Diabetes	40
Dementia	9
Cancer	10

eye procedures	2015
injections	313

**Gender**
Male	139
Female	219

**Ethnicity**
Non-Hispanic White	321
Black	21
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	111
From 75 to 84	107
85 and over	100
Less than 65	40

Hypertension	69
High Cholesterol	55
Stroke	6
Ischemic Heart Disease	43
Depression	14
Chronic Kidney Disease	34
Asthma	18
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	15
Diabetes	39
Dementia	12
Cancer	11

eye procedures	1619
injections	206

**Gender**
Male	108
Female	174

**Ethnicity**
Non-Hispanic White	244
Black	19
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	85
From 75 to 84	78
85 and over	82
Less than 65	37

Hypertension	72
High Cholesterol	50
Stroke	0
Ischemic Heart Disease	43
Depression	20
Chronic Kidney Disease	39
Asthma	5
Osteoperosis	9
Atrial Fibrilation	13
Heart Failure	20
Chronic Obstructive Pulmonary Disease	17
Diabetes	39
Dementia	12
Cancer	13

eye procedures	1657
injections	217

**Gender**
Male	112
Female	172

**Ethnicity**
Non-Hispanic White	254
Black	12
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	82
From 75 to 84	86
85 and over	80
Less than 65	36

Hypertension	69
High Cholesterol	57
Stroke	4
Ischemic Heart Disease	38
Depression	20
Chronic Kidney Disease	36
Asthma	7
Osteoperosis	10
Atrial Fibrilation	15
Heart Failure	22
Chronic Obstructive Pulmonary Disease	12
Diabetes	35
Dementia	12
Cancer	12

doctor visit	23
eye procedures	1229
injections	135

**Gender**
Male	92
Female	153

**Ethnicity**
Non-Hispanic White	220
Black	11
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	81
From 75 to 84	69
85 and over	58
Less than 65	37

Hypertension	67
High Cholesterol	56
Stroke	6
Ischemic Heart Disease	36
Depression	20
Chronic Kidney Disease	36
Asthma	6
Osteoperosis	11
Atrial Fibrilation	9
Heart Failure	18
Chronic Obstructive Pulmonary Disease	13
Diabetes	34
Dementia	11
Cancer	13

doctor visit	13
eye procedures	772
injections	63

**Gender**
Male	76
Female	121

**Ethnicity**
Non-Hispanic White	181
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	57
From 75 to 84	51
85 and over	63
Less than 65	26

Hypertension	64
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	36
Depression	21
Chronic Kidney Disease	37
Asthma	6
Osteoperosis	10
Atrial Fibrilation	13
Heart Failure	21
Chronic Obstructive Pulmonary Disease	14
Diabetes	37
Dementia	11
Cancer	11

doctor visit	215
eye procedures	284
injections	36

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Michael Thomas Trese, MD for Medicare patients.

The highest averages for the top procedures that Dr. Michael Thomas Trese, MD treated as an ophthalmologist in Royal Oak, MI were eye procedures and injections.

doctor visit	71
eye procedures	1523
injections	220

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Michael Thomas Trese, MD.

**Gender**
Male	100
Female	161

**Ethnicity**
Black / African American	8
Asian / Pacific Islander	0
Non-Hispanic White	235
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	77
85 and over	74
Less than 65	34
65 to 74	76

Average of Total of Conditions of Medicare patients treated by Dr. Michael Thomas Trese, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Michael Thomas Trese, MD treated were hypertension, high cholesterol, ischemic heart disease and diabetes.

Hypertension	56
High Cholesterol	45
Stroke	3
Ischemic Heart Disease	33
Depression	14
Chronic Kidney Disease	26
Asthma	6
Osteoporosis	8
Heart Failure	17
Chronic Obstructive Pulmonary Disease	11
Diabetes	30
Atrial Fibrillation	10
Cancer	8
Dementia	8

Education & Training

He has a state license in Michigan.

Licensed In: Michigan

Affiliations & Hospitals

Dr. Michael Thomas Trese, MD is associated with these hospitals and organizations:

Associated Retinal Consultants

Ratings & Reviews

Dr. Michael Thomas Trese, MD does not have any reviews yet, be the first to leave a review of Dr. Michael Thomas Trese, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael Thomas Trese, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
ThromboGenics, Inc.	$140,538 JETREA $140,538
Synergetics USA, Inc	$66,810 OPHTHALMIC INSTRUMENTS $16,667	$50,143
Regeneron Pharmaceuticals, Inc.	$29,384 Eylea $26,010	$3,374
Novartis Pharmaceuticals Corporation	$1,169 LUCENTIS $1,169
Alcon Laboratories Inc	$145 Vitreoretinal Equipment $21	$125
Other	$292 LUCENTIS $112	OZURDEX $64	VISUDYNE $14	ZIOPTAN $11	$90

**Types of Payments**
Consulting Fee	$212,675
Honoraria	$20,000
Travel and Lodging	$3,368
Food and Beverage	$1,259
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$1,000
Other	$36

Research Payments

Dr. Michael Thomas Trese, MD has received 21 research payments totaling $55,061.

Biography

Dr. Michael Trese is a physician who specializes in general practice, ophthalmology (eye disease), and optometry (primary eye care). He welcomes new patients at his office inRoyal Oak, MI as reported by Yext.